Seòmar agus comataidhean

The Scottish Government currently provides funding to support the acquisition of zero-emission buses. The Scottish Zero-Emission Bus Challenge Fund (ScotZEB) is open to bids from any party, including bus operators, acquiring buses to run on registered local bus services and aims to support swift, and significant, change in the bus market in favour of zero-emission technologies. More information on ScotZEB is available on the Transport Scotland webpages at https://www.transport.gov.scot/public-transport/buses/scottish-zero-emission-bus-challenge-fund/ .

Previously, financial support has been provided through the Scottish Ultra-Low Emission Bus Scheme, and the Scottish Green Bus Fund.

The use of the mezzanine deck on MV Hebrides is a primarily an operational decision for CalMac Ferries Ltd (CFL). CFL continue to engage with the communities and businesses who use the service regarding the use of the mezzanine deck and the potential impacts on timetables, number of sailings and overall capacity for passengers and vehicles. The mezzanine deck was brought back into use on sailings from 9 August 2021.

As of 2 August 2021:(a) 1470 vouchers have been approved for the Scottish Broadband Voucher Scheme (SBVS). We have defined this as instances where the connection has been delivered or where the voucher has been issued to a supplier but build has yet to complete. Of these, 333 vouchers have been approved through the Interim Voucher Scheme and 1137 vouchers have been approved through the Main Voucher Scheme.

Vouchers approved through the SBVS to date are broken down by local authority as follows:

Caledonian Maritime Assets Ltd (CMAL) is responsible for the procurement of ferries on behalf of Ministers.

Neither Ministers nor officials have had any meetings in the last year, either with CMAL or with third parties, to discuss the procurement of new ferry vessels specifically from foreign shipyards although the wider requirements of the open procurement for the Islay vessel has been discussed.

Transport Scotland officials have however had a number of discussions with CMAL regarding the business case for the acquisition of tonnage currently under construction in an overseas shipyard.

Our approach is for people to have access to the support they may need for assessment, diagnosis, care and rehabilitation in a setting that is as close to their home as possible. This is being supported through local primary care teams, community based rehabilitation services and secondary care investigation where needed.

NHS Boards, including our Island Boards are developing pathways according to local services and the needs of their respective populations, to support people with long COVID. We continue to engage with Boards to identify their support needs in relation to delivering care and support to people with long COVID.

In addition, we have invested over £460,000 in Chest, Heart and Stroke Scotland to enable them to deliver their ‘Long COVID support service’ which complements the support being provided by NHS Scotland.

A publication by Public Health Scotland on 26th January 2021 showed the total number of GPs in Scotland was 5,134 as at 30th September 2020, a rise of 89 compared to 2019.

Public Health Scotland are currently analysing data collected from the 2019 Workforce Survey, which will show the Whole Time Equivalent (WTE) figure for GPs in Scotland. Scottish Government are planning to collect WTE data on an annual basis going forward.

Anyone who has received either their first or second dose of the vaccine in Scotland can access a physical copy of their record of vaccination. They can request their record for the dose received in Scotland via the helpline on 0808 196 8565 or the website www.nhsinform.scot/covid19status . We are working at pace to align vaccination records from different nations of the UK.

There are no plans to undertake a metastatic breast cancer audit. Officials continue to closely monitor all patients referred with an urgent suspicion of cancer in NHS Scotland to ensure they are seen and treated as timely as possible.

I refer the member to the answer to question S6W-01559 on
‎ 24 August 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The Serum Institute of India (SII) manufactures both Vaxzevria and Covishield, both branded vaccines are exactly the same COVID-19 AstraZeneca vaccine. All SII-made doses approved by the Medicines & Healthcare products Regulatory Agency (MHRA) and administered in the UK were those branded as the ’COVID-19 vaccine AstraZeneca’ which is now known commercially as ‘Vaxzeria’. The MHRA has not approved doses branded as ‘Covishield’ and none were in administered in the UK.

All AstraZeneca vaccines given in the UK are the same product and appear on the NHS Vaccination status letter as Vaxzevria. The European Medicines Agency has authorised this vaccine and we are confident travel will not be affected.

Individuals can access the batch number of the vaccine they received in Scotland via a Subject Access Request from their GP.